跳至主要内容
临床试验/JPRN-UMIN000018139
JPRN-UMIN000018139已完成未知

Effects on cardiac, renal, and vascular endothelial markers after switching to topiroxostat from febuxostat treatment among IGT patients - Effects on cardiac, renal, and vascular endothelial markers after switching to topiroxostat from febuxostat treatment among IGT patients

Diabetes and Lifestyle Center, Tomonaga Clinic0 个研究点目标入组 100 人开始时间: 2015年6月30日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who fall into any of the following conditions are excluded: 1. Have a history of hypersensitiveness to topiroxostat, febuxostat, or allopurinol 2. Currently on mercaptopurine hydrate (including those who plan to use) 3. Currently on azathioprine (including those who plan to use) 4. Cancer-carrying (excepts for those completely cured) 5. ALT or AST value is twice higher than the standard value set by each institution 6. Complicated with chronic hepatitis (type B or C) and classified as active 7. Complicated with hepatic cirrhosis 8. Other conditions that may be judged by a (responsible) investigator to be inappropriate to this study

研究者

发起方
Diabetes and Lifestyle Center, Tomonaga Clinic

相似试验